Cannabis Law Report

JULY 27, 2022

As a Schedule I substance under the Controlled Substances Act, marijuana has a high potential for abuse and no currently accepted medical use in treatment in the United States and lacks accepted safety for use under medical supervision. Food and Drug Administration (FDA) has federal authority to approve drugs for medicinal use in the U.S.

Marijuana 52

Marijuana DEA State Laws Policy 52

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. submitted his first DEA application to manufacture marijuana for use in medical research.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

AUGUST 5, 2021

State opt-out- States’ rights would be preserved with the authority of states to set their own marijuana policies and keep it illegal, but states would not be able to stop product from being transported through their state. There will also be a role for the Treasury and the Consumer Product Safety Commission. Some Thoughts.

Banking 111

Banking Vaping Education DEA 111